Pathogenesis of type 2 diabetes mellitus

被引:454
作者
Leahy, JL [1 ]
机构
[1] Univ Vermont, Coll Med, Burlington, VT 05405 USA
关键词
type; 2; diabetes; pathogenesis; genetic predisposition; insulin resistance; beta-cell dysfunction;
D O I
10.1016/j.arcmed.2005.01.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The pathological sequence for type 2 diabetes is complex and entails many different elements that act in concert to cause that disease. This review proposes a sequence of events and how they interact by a careful analysis of the human and animal model literature. A genetic predisposition must exist, although to date very little is known about specific genetic defects in this disease. Whether the diabetes phenotype will occur depends on many environmental factors that share an ability to stress the glucose homeostasis system, with the current explosion of obesity and sedentary lifestyle being a major cause of the worldwide diabetes epidemic. We also propose that a lowered beta-cell mass either through genetic and/or beta-cell cytotoxic factors predisposes for glucose intolerance. As the blood glucose level rises even a small amount above normal, then acquired defects in the glucose homeostasis system occur-initially to impair the beta cell's glucose responsiveness to meals by impairing the first phase insulin response-and cause the blood glucose level to rise into the range of impaired glucose tolerance (IGT). This rise in blood glucose, now perhaps in concert with the excess fatty acids that are a typical feature of obesity and insulin resistance, cause additional deterioration in beta-cell function along with further insulin resistance, and the blood glucose levels rise to full-blown diabetes. This sequence also provides insight into how to better prevent or treat type 2 diabetes, by studying the molecular basis for the early defects, and developing targeted therapies against them. (c) 2005 IMSS. Published by Elsevier Inc.
引用
收藏
页码:197 / 209
页数:13
相关论文
共 112 条
[1]
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action [J].
Aguirre, V ;
Werner, ED ;
Giraud, J ;
Lee, YH ;
Shoelson, SE ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1531-1537
[2]
[Anonymous], 1996, Diabetes Rev
[3]
Regulation of fasted blood glucose by resistin [J].
Banerjee, RR ;
Rangwala, SM ;
Shapiro, JS ;
Rich, AS ;
Rhoades, B ;
Qi, Y ;
Wang, J ;
Rajala, MW ;
Pocai, A ;
Scherer, PE ;
Steppan, CM ;
Ahima, RS ;
Obici, S ;
Rossetti, L ;
Lazar, MA .
SCIENCE, 2004, 303 (5661) :1195-1198
[4]
DIABETES IN IDENTICAL-TWINS - A STUDY OF 200 PAIRS [J].
BARNETT, AH ;
EFF, C ;
LESLIE, RDG ;
PYKE, DA .
DIABETOLOGIA, 1981, 20 (02) :87-93
[5]
PHYSIOLOGIC EVALUATION OF FACTORS CONTROLLING GLUCOSE-TOLERANCE IN MAN - MEASUREMENT OF INSULIN SENSITIVITY AND BETA-CELL GLUCOSE SENSITIVITY FROM THE RESPONSE TO INTRAVENOUS GLUCOSE [J].
BERGMAN, RN ;
PHILLIPS, LS ;
COBELLI, C .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (06) :1456-1467
[6]
EFFECTS OF A 48-H FAT INFUSION ON INSULIN-SECRETION AND GLUCOSE-UTILIZATION [J].
BODEN, G ;
CHEN, XH ;
ROSNER, J ;
BARTON, M .
DIABETES, 1995, 44 (10) :1239-1242
[7]
Nutritional effects of fat on carbohydrate metabolism [J].
Boden, G ;
Carnell, LH .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 17 (03) :399-410
[8]
FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis [J].
Boden, G ;
Cheung, P ;
Stein, TP ;
Kresge, K ;
Mozzoli, M .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (01) :E12-E19
[9]
The role of TNF-α in insulin resistance [J].
Borst, SE .
ENDOCRINE, 2004, 23 (2-3) :177-182
[10]
PHYSIOLOGICAL IMPORTANCE OF DEFICIENCY IN EARLY PRANDIAL INSULIN-SECRETION IN NON-INSULIN-DEPENDENT DIABETES [J].
BRUCE, DG ;
CHISHOLM, DJ ;
STORLIEN, LH ;
KRAEGEN, EW .
DIABETES, 1988, 37 (06) :736-744